These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16439034)

  • 1. A case of slowly progressive type 1 diabetes with unstable glycemic control caused by unusual insulin antibody and successfully treated with steroid therapy.
    Matsuyoshi A; Shimoda S; Tsuruzoe K; Taketa K; Chirioka T; Sakamoto F; Sakakida M; Miyamura N; Araki E
    Diabetes Res Clin Pract; 2006 Jun; 72(3):238-43. PubMed ID: 16439034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin antibodies in patients with type 2 diabetes mellitus].
    Martinka E; Straková J; Mokán M
    Vnitr Lek; 1998 Oct; 44(10):577-81. PubMed ID: 10422490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of insulin antibodies in insulin treatment of type I diabetes.
    Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W
    Exp Clin Endocrinol; 1986 Jun; 87(1):79-88. PubMed ID: 3527726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes.
    Wagner H; Degerblad M; Thorell A; Nygren J; Ståhle A; Kuhl J; Brismar TB; Ohrvik J; Efendic S; Båvenholm PN
    Diabetes Care; 2006 Jul; 29(7):1471-7. PubMed ID: 16801564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of syndrome X whose hyperglycemia, hyperlipidemia and hypertension were improved as accompanying with decreased insulin resistance].
    Hiramatsu S; Mimura K; Ono Y; Taniguchi S; Iwashige K; Umeda F; Nawata H
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):326-8. PubMed ID: 7851834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.
    Radermecker RP; Renard E; Scheen AJ
    Diabetes Metab Res Rev; 2009 Sep; 25(6):491-501. PubMed ID: 19496088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatment.
    Keilacker H; Rjasanowski I; Ziegler M; Michaelis D; Woltanski KP; Besch W
    Horm Metab Res; 1982 May; 14(5):227-32. PubMed ID: 7047344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE
    J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early onset insulin-dependent diabetes mellitus as an initial manifestation of aceruloplasminaemia.
    Muroi R; Yagyu H; Kobayashi H; Nagata M; Sato N; Ideno J; Fujita N; Ando A; Okada K; Takiyama Y; Nagasaka S; Miyajima H; Nakano I; Ishibashi S
    Diabet Med; 2006 Oct; 23(10):1136-9. PubMed ID: 16978380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria.
    Schütt M; Kern W; Krause U; Busch P; Dapp A; Grziwotz R; Mayer I; Rosenbauer J; Wagner C; Zimmermann A; Kerner W; Holl RW;
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):384-8. PubMed ID: 16915542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic instability in type 1 diabetic patients: Possible role of ketosis or ketoacidosis at onset of diabetes.
    Sassa M; Yamada Y; Hosokawa M; Fukuda K; Fujimoto S; Toyoda K; Tsukiyama K; Seino Y; Inagaki N
    Diabetes Res Clin Pract; 2008 Aug; 81(2):190-5. PubMed ID: 18514964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
    Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
    Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes.
    Saukkonen T; Shojaee-Moradie F; Williams RM; Amin R; Yuen KC; Watts A; Acerini CL; Umpleby AM; Dunger DB
    Diabetes; 2006 Aug; 55(8):2365-70. PubMed ID: 16873702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin glargine maintains equivalent glycemic control and better lipometabolic control than NPH insulin in type 1 diabetes patients who missed a meal.
    Rosak C; Jung R; Hofmann U
    Horm Metab Res; 2008 Aug; 40(8):544-8. PubMed ID: 18493882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics and crossreactivity of insulin autoantibodies and insulin antibodies directed to three different insulin molecules.
    Jaeger C; Winter S; Eckhard M; Hardt P; Brendel MD; Bretzel RG
    Acta Diabetol; 2008 Sep; 45(3):191-4. PubMed ID: 18493700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA; Kane MP; Busch RS
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of therapy-induced insulin antibodies on glycemic control in type 1 diabetes mellitus.
    Keilacker H; Rjasanowski I; Ziegler M
    Z Med Lab Diagn; 1989; 30(1):65-6. PubMed ID: 2655328
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.